- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Small Cell Lung Carcinoma (SCLC)
Total 14598 results
-
PTS International Inc.Completed
-
National Cancer Institute (NCI)TerminatedExtensive Stage Lung Small Cell CarcinomaUnited States
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUnresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.TerminatedNSCLC Stage IV | NSCLC, Stage IIICUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
University Hospital, Strasbourg, FranceRecruitingNSCLC | IMMUNOTHERAPY | QUANTIFICATION OF CELL-FREE DNAFrance
-
University Health Network, TorontoOICRNot yet recruitingNon-Small Cell Lung Cancer (NSCLC) | Clinical Staging T2b-3 N0-1 M0
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlatinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Extensive Stage Lung Small Cell Carcinoma | Refractory Extensive Stage Lung Small Cell CarcinomaUnited States
-
Sunshine Lake Pharma Co., Ltd.Not yet recruiting
-
Qilu Hospital of Shandong UniversityUnknown
-
National Cancer Institute (NCI)Active, not recruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
Elevation OncologyMerrimack PharmaceuticalsTerminatedAdenocarcinoma | Non-Small Cell Lung Cancer | NSCLC | HeregulinSpain, Canada, United States, Germany, Hungary, France
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced NSCLC | Recurrent NSCLCChina
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHRecruitingLocally Advanced or Metastatic NSCLCChina
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Beta Pharma ShanghaiActive, not recruiting
-
Armando Santoro, MDTerminated
-
Allist Pharmaceuticals, Inc.UnknownAdvanced NSCLC Patients With T790MChina
-
Xiaorong DongUnknownHealthy Subjects | NSCLC Stage IV | NSCLC, Stage III | NSCLC, Stage I | NSCLC, Stage IIChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingNSCLC | Neoadjuvant TherapyChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)Israel, Taiwan, United States, Australia, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia
-
Kai-Uwe Schmitt, PhD, MEng, ICIDRecruitingNon-Small Cell Lung Cancer (NSCLC)Switzerland
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
AstraZenecaCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Mexico
-
University of WashingtonNational Cancer Institute (NCI); Imago BioSciences, Inc., a subsidiary of Merck...Active, not recruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Stand Up To Cancer; Iovance Biotherapeutics, Inc.; Prometheus...CompletedNon-Small Cell Lung Cancer | Adenocarcinomas | Squamous Cell Carcinoma | Advanced NSCLC | Metastatic Non-small Cell Lung Cancer | Adenosquamous CarcinomaUnited States
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
AkesoNot yet recruitingLocally Advanced or Metastatic NSCLCChina
-
Guangdong Provincial People's HospitalRecruiting
-
National Taiwan University HospitalActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.UnknownLocally Advanced or Metastatic NSCLCChina
-
International Group of Endovascular OncologyAzienda Sanitaria OspedalieraUnknownLocally Advanced/ Metastatic NSCLCItaly
-
Peking Union Medical College HospitalUnknown
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting